You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 82 No. 1, January 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  Papers Presented at the Eighth Scientific Meeting of the North American Chapter of the International Cardiovascular Society, Miami Beach, June 11, 1960
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Experimental Atherosclerosis and Portacaval Shunt

FERDINAND F. McALLISTER, M.D.; ROBERT BERTSCH, M.D.; GERARD D'ALESSIO, B.S.

AMA Arch Surg. 1961;82(1):66-68.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The role of the liver in cholesterol metabolism and experimental atherogenesis is not completely understood. Katz and Stamler1 in their familiar monograph on "Experimental Atherosclerosis" state that, to their knowledge, "no thorough-going studies have been carried out on the influence of hepatic factors on atherogenesis in experimental animals." According to the texts, free cholesterol exists in the blood stream as a result of the breakdown of erythrocytes and other cells and is excreted by the liver in bile—the only body fluid in which it is readily soluble. In addition, the liver may synthesize cholesterol from acetate by a process involving some 26 separate enzymatic reactions. According to Siperstein and Guest,2 exogenous cholesterol may exert some control over this synthesis by a feedback mechanism probably blocking the synthesis prior to the formation of squalene. Little else appears to be known of the handling of exogenous cholesterol by the liver. . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Department of Surgery, Columbia University, College of Physicians and Surgeons.


Footnotes

Submitted for publication June 16, 1960.

Aided by Grants from the New York Heart Association and the United States Public Health Service.

Read before the Eighth Scientific Meeting of the International Cardiovascular Society, North American Chapter, Miami Beach, June 11, 1960.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.